CMO Frontida invests equity in Oncoceutics to establish long-term relationship
Frontida BioPharm has made an equity investment in Oncoceutics as part of a product development and commercialization agreement to advance the company's lead compound.
Archives for January 10, 2018
Datavant takes step towards goal of doubling clinical trials success rate
Datavant has integrated its 150th dataset through a partnership that will “transform” the drug development process, says co-founder.
Covance: New offering applies Chiltern-developed engagement models
LabCorp’s Covance has launched a new dedicated offering for biotech, medical device, and diagnostic companies following its purchase of Chiltern in 2017.
Lonza emphasises new track and trace capabilities at Scotland facility
Lonza has joined contractors predicting high demand for services that comply with track and trace rules due to be introduced in the EU and US.
News in brief
API distributor American International Chemical bought by private equity firm
Investment firm LeBaronBrown Llc has acquired American International Chemical Inc (AIC), a distributor of ingredients for the pharmaceutical sector and other industries.
Infliximab monograph adopted by European Pharmacopoeia Commission
European Pharmacopoeia Commission has adopted the first monograph for a monoclonal antibody and is poised to add it to the European Pharmacopoeia.
Novartis to test Intec's Accordion controlled-release delivery tech
Novartis will trial a controlled release technology – dubbed the Accordion Pill – under an agreement with developer Intec Pharma Ltd.